Maharshtra to face shortage of Remdesivir for next 2 to 3 days: Minister
State FDA Minister Rajendra Shingane said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach market.
Share Via Email
| A+A A- By PTI
MUMBAI: Maharashtra will face a shortage of 12,000 to 15,000 Remdesivir injections, used to treat COVID-19 patients, for the next two to three days, state Food and Drug Administration (FDA) Minister Rajendra Shingane said on Friday.
He said pharma companies manufacturing Remdesivir have stepped up production but it will take time for the new stock to reach the market.
Mumbai
Maharashtra
India
Sun-pharma
Uddhav-thackeray
Rajendra-shingane
Cipla-ltd
Zydus-cadilla-healthcare-ltd
Drug-administration
Hetero-labs-ltd
Dr-reddy-laboratories-ltd
Minister-rajendra-shingane
1777 Registering a steady rise for the 37th day in a row, the active cases rose to 15,69,743, comprising 10.98 per cent of the total infections. Tribune Photo: Mukesh Aggarwal
New Delhi, April 16
As India recorded over two lakh new COVID-19 cases for the second straight day, the Centre on Friday unveiled plans to ramp up output of indigenous vaccine Covaxin ten times to reach 10 crore doses by September and accelerate the manufacture of antiviral drug remdesivir, and also called for increasing the production of medical oxygen.
In the wake of reports of shortage of the medical grade oxygen for COVID-19 patients in different parts of the country in the last few days, Prime Minister Narendra Modi undertook a comprehensive review to ensure its adequate supply, and said steps should be taken to augment the production. He also asked officials to ensure seamless and free movement of tankers carrying this commodity throughout the country.
India
Bulandshahr
Uttar-pradesh
Karnataka
United-kingdom
New-delhi
Delhi
Brazil
South-africa
Bangalore
Kerala
Madhya-pradesh